Gene · 51135
Papers3,419
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,419
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| AGE-RAGE axis culminates into multiple pathogenic processes: a central road to neurodegeneration. | Front Mol Neurosci | 2023 | 37266370 | PubTator, text mining | PubMed |
| Identification of the immune-related biomarkers in Behcet's disease by plasma proteomic analysis. | Arthritis Res Ther | 2023 | 37264476 | PubTator, text mining | PubMed |
| The Current Clinical Trial Landscape for Hidradenitis Suppurativa: A Narrative Review. | Dermatol Ther (Heidelb) | 2023 | 37261652 | PubTator, text mining | PubMed |
| PROTACs: A novel strategy for cancer drug discovery and development. | MedComm (2020) | 2023 | 37261210 | PubTator, text mining | PubMed |
| PROTACs: Emerging Targeted Protein Degradation Approaches for Advanced Druggable Strategies. | Molecules | 2023 | 37241755 | PubTator, text mining | PubMed |
| Mutations in the Vicinity of the IRAK3 Guanylate Cyclase Center Impact Its Subcellular Localization and Ability to Modulate Inflammatory Signaling in Immortalized Cell Lines. | Int J Mol Sci | 2023 | 37239919 | PubTator, text mining | PubMed |
| Proanthocyanidins: A novel approach to Henoch‑Schonlein purpura through balancing immunity and arresting oxidative stress via TLR4/MyD88/NF‑κB signaling pathway (Review). | Exp Ther Med | 2023 | 37229322 | PubTator, text mining | PubMed |
| Increased expression of miR146a dysregulates TLR2-induced HBD2 in airway epithelial cells from patients with COPD. | ERJ Open Res | 2023 | 37228294 | PubTator, text mining | PubMed |
| A publication-wide association study (PWAS), historical language models to prioritise novel therapeutic drug targets. | Sci Rep | 2023 | 37225853 | PubTator, text mining | PubMed |
| Forces exerted and transduced by cancer-associated fibroblasts during cancer progression. | Biol Cell | 2023 | 37224184 | PubTator, text mining | PubMed |
| Reducing Boolean networks with backward equivalence. | BMC Bioinformatics | 2023 | 37221494 | PubTator, text mining | PubMed |
| Innate immune regulations and various siRNA modalities. | Drug Deliv Transl Res | 2023 | 37219704 | PubTator, text mining | PubMed |
| The role of circulating cell-free DNA as an inflammatory mediator after stroke. | Semin Immunopathol | 2023 | 37212886 | PubTator, text mining | PubMed |
| Single-cell atlas of the human neonatal small intestine affected by necrotizing enterocolitis. | PLoS Biol | 2023 | 37205711 | PubTator, text mining | PubMed |
| Emerging functions of pseudoenzymes. | Biochem J | 2023 | 37204401 | PubTator, text mining | PubMed |
Design, synthesis, and pharmacological evaluation of N-(3-carbamoyl-1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide derivatives as interleukin-1 receptor-associated kinase 4 inhibitors with reduced potential for cytochrome P450 1A2 induction. | Bioorg Med Chem | 2023 | 37201454 | PubTator, text mining | PubMed |
| Novel Agents in Waldenström Macroglobulinemia. | Hematol Oncol Clin North Am | 2023 | 37198054 | PubTator, text mining | PubMed |
| PROTAC Targeted Degradation of IRAK-4 as Potential Treatment in Cancer. | ACS Med Chem Lett | 2023 | 37197458 | PubTator, text mining | PubMed |
| Novel CDK12/13 Inhibitors AU-15506 and AU-16770 Are Potent Anti-Cancer Agents in EGFR Mutant Lung Adenocarcinoma with and without Osimertinib Resistance. | Cancers (Basel) | 2023 | 37190191 | PubTator, text mining | PubMed |
| What's Next after Hypomethylating Agents Failure in Myeloid Neoplasms? A Rational Approach. | Cancers (Basel) | 2023 | 37190176 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51135/papers?page=20